Lunch Workshops

REQUIRED: Separate registration fee of $50.00; includes a box lunch and ACPE credits. Participation is limited to 75 so register early.

Wednesday, April 23, 12:00pm - 2:00pm

Nephrotic Syndrome in 2014

Session 233

Chairs: Daniel Cattran, MD, and Debbie Gipson, MD, FNKF
Presenters: Debbie Gipson, MD, FNKF, Cynthia Nast, MD, and Daniel Cattran, MD
This workshop will provide attendees with an overview of the epidemiology of nephrotic syndrome and associated conditions and the prognostic importance of the biopsy on clinical care, and will review evidence-based guidelines for patient management. Practical aspects of managing the nephrotic patient will be discussed, including tailoring treatment based on proteinuria and eGFR, complication prevention strategies, and a review of the new findings ready for the clinical arena.


Session 235

Chair: Kamel Kamel, MD, FRCPC
Presenters: Mark Perazella, MD, FNKF, Kamel Kamel, MD, FRCPC and Joseph Verbalis, MD
This session will cover three complex clinical areas that relate to and are critical for the practicing nephrologist. The first topic will review the clinical presentation and management of acid-base abnormalities that occur as a result of toxic ingestions. The second will review the use of aquaporin-2 antagonists in chronic hyponatremia and kidney diseases, including polycystic disease. The final topic will review clinical manifestations, including electrolyte disturbances and nephrotoxicity of recreational drug ingestion and related management strategies. Each session will include the presentation of a few interesting cases in an interactive format with the audience.

Friday, April 25, 11:30am - 1:00pm

Controversies in the Management of Hypertension in Dialysis Patients

Session 237

Chair: Wendy St. Peter, PharmD, FCCP, FASN, FNKF
Presenters: Aldo Peixoto, MD, Wendy St. Peter, PharmD, FCCP, FASN, FNKF, and Tara Chang, MD, MS
Treating hypertension in both peritoneal and hemodialysis patients is complex, and involves many factors, such as dry weight estimation, volume gain and shifts during treatment, interdialytic changes in blood pressure, and limited data supporting the efficacy and evidence base for various antihypertensives. Choosing the appropriate blood pressure target and optimal medication in peritoneal and hemodialysis patients can be challenging. Gaining a working knowledge base of the data supporting various management strategies and blood pressure targets will help clinicians optimally manage hypertension in these patients. This workshop will provide participants with an evaluation of the current state of the literature in relation to blood pressure targets, and will focus on the utility and evidence base for the use of ace inhibitors and diuretics in these patients.

Managing the Pre-ESRD Patient

Session 240

Chair: Michal Melamed, MD, MHS, FNKF
Presenters: Jerry Yee, MD, FNKF, FASN, FNKF Carolyn Cochran, MS, RD, LD, CDE, and Jeffrey Berns, MD, FNKF
The management of the pre- ESRD patient is often a complex balance of dietary, medication, and other interventions in preparation for dialysis. As kidney function deteriorates, medication safety, nutrition, and discussions of renal replacement therapy become increasingly important. During this workshop, important classes of medications that need monitoring or stopping will be reviewed. A dietitian will review dietary recommendations for late-stage CKD, when kidney function is almost gone, but patients are not yet on renal replacement therapy. Lastly, guiding patients and their families in a timely fashion towards appropriate renal replacement therapy options will be reviewed. This workshop will present a unique opportunity to discuss last-minute strategies for keeping patients safe and healthy before initiation of dialysis.